1 00:00:00,600 --> 00:00:05,460 Right. So could you just start by saying your name and your current position and affiliation? 2 00:00:05,790 --> 00:00:13,200 Yes. My name is William James. I'm professor of virology at the Sir William Dunn School of Pathology and a teacher in medicine at Prisoners College. 3 00:00:13,470 --> 00:00:17,880 Lovely. And without telling me your entire life story. 4 00:00:18,510 --> 00:00:23,520 But starting with how you first got interested in medicine, can you just give me your career highlights so far? 5 00:00:23,550 --> 00:00:32,610 Yes. Well, I studied Basic Biological Sciences as an undergraduate in Birmingham and was actually most interested in genetics, 6 00:00:32,610 --> 00:00:43,620 because genetics was a very strong subject there. And my my passion for doing research was ignited by getting a summer project. 7 00:00:43,830 --> 00:00:55,590 Um, uh, being offered a summer project while I was in Birmingham to work on was one of the lectures there on the genetics of control of bacterial, 8 00:00:55,970 --> 00:01:04,020 uh, differentiation. And I just became addicted to doing research myself and then doing a patient. 9 00:01:04,020 --> 00:01:12,630 It's natural thing to do. And there was a very prominent group in, in Oxford working on a related topic. 10 00:01:12,780 --> 00:01:19,890 And so I came to work with Joel Mandelstam in the biochemistry department on Bacillus, um, genetics then. 11 00:01:20,730 --> 00:01:27,959 And at the end of that Ph.D., which went quite well, um, I was offered a, uh, an academic post, 12 00:01:27,960 --> 00:01:35,790 temporary academic post in the Dunn School to teach the medical students bacteriology, which I foolishly agreed to do. 13 00:01:36,300 --> 00:01:44,070 And so I spent the next five or six, six years, I think, um, teaching the medical students bacteriology. 14 00:01:44,070 --> 00:01:52,530 That's what I paid to do. But I'm in the, uh, in the rest of my time, probably about three course of my time learning, 15 00:01:52,560 --> 00:01:58,590 uh, methods in molecular biology, monoclonal antibodies and virology. 16 00:01:58,590 --> 00:02:05,280 Importantly from James Porterfield, who was a great leader in the, um, in the, in the virus world. 17 00:02:06,180 --> 00:02:17,610 So that's how I got into viruses. And uh, after a fairly short time doing my own research on viruses, I decided that HIV, 18 00:02:17,610 --> 00:02:22,349 which is in the mid eighties, we talk about now, was the big topic to investigate. 19 00:02:22,350 --> 00:02:27,059 So I started working on HIV then and I cut a long story short. 20 00:02:27,060 --> 00:02:35,700 I carried on working on HIV for most of the rest of my career and the aspect that was the main focus. 21 00:02:36,570 --> 00:02:45,060 I had many little digressions, but the main focus has been how the virus infects one particular type of cell in the body called the macrophage, 22 00:02:46,380 --> 00:02:51,540 which is a coordinating cell in immune response and in tissue homeostasis. 23 00:02:55,810 --> 00:03:04,720 So that went very well. And we got to a point with those sorts of studies and the macrophage is a host for many other viruses as well, like dengue. 24 00:03:05,190 --> 00:03:09,069 And so. So what do the macrophages do? Well, macrophages. 25 00:03:09,070 --> 00:03:14,680 Well, they do sort of everything. They're macrophages or cells like macrophages. 26 00:03:14,680 --> 00:03:16,540 Been with us ever since we were sponges. 27 00:03:16,990 --> 00:03:22,840 You basically can't be a multicellular organisms without a little community policeman type cell like a macrophage, 28 00:03:23,620 --> 00:03:28,000 making sure there are no cells, being naughty and taking over the whole the whole body. 29 00:03:28,870 --> 00:03:37,240 In addition to which, they they gobble up foreign bodies, tidying them away and and any dead cells have to be there. 30 00:03:37,840 --> 00:03:41,860 And they encourage cells to grow when they need to grow and not when they don't. 31 00:03:43,300 --> 00:03:47,260 And all they specific are they know then that they're generalists. 32 00:03:47,260 --> 00:03:56,379 They've got a few tools in their in their in their bag, which enables them to recognise a bacterium or many sorts of viral patterns. 33 00:03:56,380 --> 00:04:03,070 But they, they're generalists in terms of antigens. They're not like lymphocytes that are able to recognise particular antigens. 34 00:04:04,180 --> 00:04:12,770 So as evolution went along and we got more and more complicated, the way we developed macrophages is also changed. 35 00:04:12,770 --> 00:04:18,430 So we now make macrophages as adults. Most of them we make from a blood cell called a monocyte, 36 00:04:18,910 --> 00:04:24,610 although they still are the residue of some of those most primitive type of macrophages in some of our tissues, 37 00:04:24,610 --> 00:04:27,730 like in the brain, indeed microglia of the brain, 38 00:04:27,740 --> 00:04:35,380 a type of macrophage that comes from that very early sponge sort of stage of of of macrophage biology. 39 00:04:36,610 --> 00:04:43,570 But because they are the sort of very mobile cell like amoeba, people remember what amoeba are like. 40 00:04:43,720 --> 00:04:52,960 They can move around. Unlike most body cells under their own power, they can hunt, seek out and destroy or what have you. 41 00:04:54,100 --> 00:04:57,940 So that makes them really very powerful and important in maintaining our tissues. 42 00:04:58,240 --> 00:05:03,129 And how do they interact with viruses? They interact with viruses in a number of ways. 43 00:05:03,130 --> 00:05:07,900 They've got a number of. Yes, there's quite a few ways they can interact with viruses. 44 00:05:08,140 --> 00:05:14,920 They've got a number of surface receptors that recognise certain common patterns 45 00:05:14,920 --> 00:05:20,440 in viruses which will enable them to hoover them up and and destroy them. 46 00:05:20,450 --> 00:05:29,950 Except, of course, it's the viruses evolved specifically to parasitised the macrophage and there are viruses that have have evolved to do that. 47 00:05:29,950 --> 00:05:38,200 And some of the, uh, viruses like Zika virus and dengue virus have, have indeed and been able to do that. 48 00:05:38,620 --> 00:05:46,750 And then inside the cell, they've got a lot of defence systems for recognising and responding to virus infection. 49 00:05:47,050 --> 00:06:00,520 So that's quite hard to infect as we'll maybe come up to a bit later of relation to SARS-CoV-2 for most non-specialist specialist viruses anyway. 50 00:06:01,580 --> 00:06:08,830 Long story short, the HIV experiments kept hitting a brick wall, which was a technical brick wall. 51 00:06:09,130 --> 00:06:16,180 But in order to really delve deeply into any particular aspect of the biology, of the interaction of the virus and the macrophage. 52 00:06:16,540 --> 00:06:25,200 So, for example. Sorry, I should just. Interject there that even in the modern era of well-controlled HIV infection, 53 00:06:25,470 --> 00:06:31,080 there is remains persistent infection of, for example, the microglia in the brain. 54 00:06:31,410 --> 00:06:38,520 And it's that that's responsible for some of the neurocognitive defects that you still see even in people controlling virus. 55 00:06:38,880 --> 00:06:40,440 So that's why it still remains important. 56 00:06:42,120 --> 00:06:54,480 But to try and study these processes really powerfully, we needed to be able to do modern molecular genetics on the cell as well as the virus, 57 00:06:55,890 --> 00:07:01,890 to test the hypothesis that Gene Product X was responsible for whatever the process was. 58 00:07:02,460 --> 00:07:14,040 And because macrophages have evolved to recognise any foreign DNA or RNA, you might throw at them as if it were a virus or a bacterium. 59 00:07:14,640 --> 00:07:25,260 It's extremely hard to do that. So about 15 years ago, I and my team developed a workaround for this a new methodology, 60 00:07:25,920 --> 00:07:31,740 starting with pluripotent stem cells, which means embryonic stem cells, and now these induced pluripotent stem cells. 61 00:07:32,250 --> 00:07:39,030 So these are non differentiated. So clearly undifferentiated induced to exactly develop different pathways. 62 00:07:39,060 --> 00:07:43,350 Exactly. They're undifferentiated human cells, which are normal genetically. 63 00:07:43,360 --> 00:07:47,820 So most of the cells people use in the abnormal genetic, they come from cancers. 64 00:07:48,030 --> 00:07:53,099 But these are normal, genetically undifferentiated. But we can monkey around with their genes. 65 00:07:53,100 --> 00:07:59,880 We're using clever techniques like CRISPR and so on, and then we can differentiate them down different pathways. 66 00:08:00,690 --> 00:08:04,799 And so we developed the macrophage differentiation pathway for these cells that 67 00:08:04,800 --> 00:08:10,170 many labs around the world now use and have used those tools in the HIV field. 68 00:08:10,440 --> 00:08:18,130 So you can just make macrophages. We can just churn out factories of macrophages, which is it's work much better than, frankly, I deserved. 69 00:08:20,430 --> 00:08:23,160 Well, sometimes one gets lucky and often one doesn't. 70 00:08:24,390 --> 00:08:31,730 That methodology has turned out to be terribly important, not only for the virus world, but also for the neurodegeneration. 71 00:08:32,040 --> 00:08:37,830 So we have quite a large program of collaborations with Alzheimer's and Parkinson's researchers, 72 00:08:38,460 --> 00:08:45,210 because a lot of what goes wrong in the brain turns out to be defects of the microglia that I mentioned before, 73 00:08:45,750 --> 00:08:51,899 failing to clear away the the things that accumulate with age and then getting 74 00:08:51,900 --> 00:08:55,950 overwhelmed by them and getting cross and then damaging the nerve cells. 75 00:08:56,460 --> 00:09:03,870 So there's been a big programme of work that Sammy currently in my lab leads on the neurodegenerative neuro inflammatory side of things, 76 00:09:03,870 --> 00:09:12,720 but I retain the focus on the virology aspects and of course is very big over continuing find this big overlap between the two. 77 00:09:13,410 --> 00:09:20,580 So that's that's where I was and to bring you up to about 2019. 78 00:09:22,020 --> 00:09:30,930 The big piece of work we were embarking on was indeed looking at how latency that is. 79 00:09:31,730 --> 00:09:39,960 The ability of virus to hide quietly inside microglial cells was regulated because if we could understand that, then we could stop it being a problem. 80 00:09:41,010 --> 00:09:47,670 And that was a quite ambitious program, but it all had to come to an end for reasons that probably are obvious to you. 81 00:09:48,480 --> 00:09:52,770 But we'll come on to that, that just kind of fill in your life story, as it were. 82 00:09:53,310 --> 00:10:01,510 And you you reached a senior position within the school, but also diverted into university administration. 83 00:10:01,530 --> 00:10:05,660 Oh, yes, yes. The dark side, as some people call it. Yes. 84 00:10:06,480 --> 00:10:11,210 Well, I think yes. What happened? 85 00:10:11,280 --> 00:10:18,239 The reason for this was quite a long process, some little tiny steps. 86 00:10:18,240 --> 00:10:25,290 So even in my very earliest days of my mid-to-late twenties as a junior academic in the dance school, um, 87 00:10:25,920 --> 00:10:32,580 there would be things that weren't working well for the department that I ended up getting the reputation of fixing, 88 00:10:32,850 --> 00:10:39,900 whether it was to do its computing systems or, or service systems or teaching systems or what have you. 89 00:10:39,930 --> 00:10:44,249 So finding solutions to those sorts of things turned out to be something. 90 00:10:44,250 --> 00:10:48,330 We like it then and, and then the financial systems was the next thing. 91 00:10:50,130 --> 00:10:57,090 And so after a while I was my role in some of that was a bit formalised by the then head of department, 92 00:10:57,090 --> 00:11:01,170 Herman Waldman, as what he'd like to call the departmental bursar. 93 00:11:01,890 --> 00:11:13,650 So we ran a very light ship administratively with me looking after the, uh, the financial strategy for the department and. 94 00:11:13,650 --> 00:11:17,970 And how it was run. And another colleague. 95 00:11:18,680 --> 00:11:23,270 Shona murthy looking after the human resources side of things. 96 00:11:24,050 --> 00:11:28,100 Otherwise we had some very, very able but quite junior finance officers and h.r. 97 00:11:28,100 --> 00:11:33,500 Officers to manage the day to day. That worked very well and I did quite enjoy that. 98 00:11:33,890 --> 00:11:38,150 Actually being able to sort things out as people seem to find difficult is always pleasurable. 99 00:11:39,260 --> 00:11:44,930 And the department did very well in that period on, on by various measures. 100 00:11:45,470 --> 00:11:54,470 And in that process I ended up. Fixing bigger issues, which ended up with building buildings. 101 00:11:54,560 --> 00:12:01,670 So I ended up developing one way or another for buildings on the done school site. 102 00:12:02,000 --> 00:12:09,680 Um, the three of them I took the lead on and the fourth one, the teaching centre was, I was just part of that of the team. 103 00:12:09,680 --> 00:12:18,110 But the first one was a single service building and I found that commissioning buildings 104 00:12:18,110 --> 00:12:23,510 to solve scientific challenges also interesting and that's been very satisfying. 105 00:12:25,520 --> 00:12:30,570 So if you can do things like that, then people ask you to do a bit more. 106 00:12:30,590 --> 00:12:43,040 And I was asked by Alistair Buchan to be his deputy when he was appointed head of medical sciences division, looking after the divisional level, 107 00:12:43,040 --> 00:12:53,570 the the financial challenges and the capital building, building challenges, and that that was quite satisfactory too. 108 00:12:55,070 --> 00:13:00,590 So I suppose the inevitable happened. Actually I had I had resisted this idea. 109 00:13:00,590 --> 00:13:08,989 I told him once before, under a previous Vice-Chancellor administration, I'd been tapped on the shoulder and said, 110 00:13:08,990 --> 00:13:14,600 Would I consider applying for TVC position or vice chancellor position? 111 00:13:14,990 --> 00:13:18,740 And at the time I said, No, I really don't want to do that sort of thing. 112 00:13:18,740 --> 00:13:23,780 I've got enough my hands full here doing my research and teaching, and that's what I would like doing. 113 00:13:23,780 --> 00:13:31,669 And I don't need to become full time in that. But about five years later, the the child was tapped again. 114 00:13:31,670 --> 00:13:41,600 And so I did apply and was appointed the pro vice chancellor by Andy Hamilton for planning and planning and resources, 115 00:13:41,600 --> 00:13:44,749 which is budgets and all that sort of stuff strategy. 116 00:13:44,750 --> 00:13:50,930 And so it's the equivalent that an American university would be provost. 117 00:13:53,390 --> 00:13:58,400 And on paper, that was absolutely perfect. 118 00:13:59,540 --> 00:14:04,580 The problem is in Oxford, and possibly not just Oxford, but in Oxford. 119 00:14:05,570 --> 00:14:10,220 Most of the job is not the technical, the logistics, the analytical, 120 00:14:11,360 --> 00:14:17,270 but it becomes more and more the higher and higher you go more about people management and politics management. 121 00:14:17,310 --> 00:14:20,180 So I don't think that was particularly my skill to them. 122 00:14:20,180 --> 00:14:25,700 So I achieved some of the things that I wanted to achieve, but some of the others were just a bit too intractable. 123 00:14:25,820 --> 00:14:29,690 And is that just because there is a certain degree of devolution within the 124 00:14:29,690 --> 00:14:34,250 university and that the technical challenges happen at divisional labs so many ways? 125 00:14:34,280 --> 00:14:37,700 Exactly like this diffusion of responsibility, which is a good thing. I don't know. 126 00:14:37,730 --> 00:14:46,309 I actually think that devolving responsibility to the lowest level sensible, that's called the subsidiary principle of subsidiarity principle, 127 00:14:46,310 --> 00:14:56,120 I think isn't it is a good thing in principle, but you do have to have some coordinating coherent structure within which those units work. 128 00:14:56,570 --> 00:15:01,639 Otherwise you're a bit like a, um, a battle fleet all sailing in different directions. 129 00:15:01,640 --> 00:15:10,190 You know, there has to be a degree of coherence and that balancing those two things has never been tackled 130 00:15:10,550 --> 00:15:15,830 constructively in Oxford in much the same way it hasn't constitutionally in this country either. 131 00:15:16,310 --> 00:15:22,910 Um, it's, it's too difficult problem, but it did mean that the sort of things that quite often became very controversial 132 00:15:22,910 --> 00:15:28,390 weren't really solvable at the university level or things that were soluble universally. 133 00:15:28,550 --> 00:15:33,980 Other people didn't want you to solve. So one way or another it was somewhat unsatisfactory. 134 00:15:33,980 --> 00:15:39,500 But when did you step down? So I did that until mid 2017. 135 00:15:40,100 --> 00:15:44,870 So I've been back at the bench with and the classroom for five years. 136 00:15:45,030 --> 00:15:49,880 Hm hm. Um. Because quickly does isn't it perception quickly. 137 00:15:50,050 --> 00:15:58,280 Um, but I haven't regretted that at all. I mean, there were obviously lots of opportunities because this is just how the world 138 00:15:58,280 --> 00:16:03,230 works to look at other positions in other universities or other organisations. 139 00:16:03,920 --> 00:16:08,720 And some of them are quite tempting on the face of it, and you don't like to be impolite and not look at them. 140 00:16:09,830 --> 00:16:13,370 But actually I did the right thing, I think. 141 00:16:13,670 --> 00:16:20,469 Well, I think so. And it gave you it must have given you an oversight of how the whole university works that you. 142 00:16:20,470 --> 00:16:24,400 Yes, I mean works in inverted commas, I think. Yes, yes, yes. 143 00:16:25,310 --> 00:16:32,750 How it goes along. So finally, let us let us get to go with the time just asking everybody this. 144 00:16:32,750 --> 00:16:39,530 Can you remember when you first heard that there was something happening in China that might be quite 145 00:16:39,530 --> 00:16:48,200 serious and affect us and and further how you might actually pivot your own research to address it? 146 00:16:48,650 --> 00:16:55,350 Well, I don't think. Can you be reliable? Yes, I well remember I was in the shower on a sunny Saturday when I heard somebody come on the radio. 147 00:16:55,620 --> 00:17:00,269 It was this growing awareness of some reports fairly early on in the beginning of 2020. 148 00:17:00,270 --> 00:17:06,179 I don't think I really was aware of it in the end of 2019, really, but they became very, 149 00:17:06,180 --> 00:17:12,480 very obvious very quickly that this was a problem like SaaS, but much worse. 150 00:17:14,730 --> 00:17:22,800 Do you have Chinese colleagues? I mean, yes. So I have colleagues both in Hong Kong. 151 00:17:23,070 --> 00:17:30,060 Well, in Hong Kong and in mainland China, in Shanghai and in Peking, some of which are some of whom I've worked on. 152 00:17:30,390 --> 00:17:44,900 So I was talking to them and um, yeah, the sense that this was a serious pandemic threat was we, we arrived at. 153 00:17:45,270 --> 00:17:48,420 I mean, I think the community arrived at very early, to be honest. 154 00:17:48,900 --> 00:17:58,180 In and within the first couple of months of the year. Easily, um, I think because it was clearly different from the original SARS virus in uh, 155 00:17:58,770 --> 00:18:04,740 I mean the key respect it was, it was that it would transmit without necessarily causing symptoms initially. 156 00:18:05,280 --> 00:18:13,170 Whereas with sars-cov-1 you got symptoms at the point you were very, very seriously ill and that was the first point to which you would transmit. 157 00:18:14,400 --> 00:18:19,290 So it was clearly a much greater threat, 158 00:18:19,290 --> 00:18:24,630 but we didn't know quite how much until it started spreading and then spread really rather rapidly, as you know. 159 00:18:25,290 --> 00:18:33,179 Um, so yes, it became very obvious by mid-February that this was something we were all going to have to take very, 160 00:18:33,180 --> 00:18:37,410 very and I know many other people were, were thinking hard about this as well. 161 00:18:38,220 --> 00:18:45,390 Um, it took a little bit longer for me decide whether that I should get involved because I've never worked on coronaviruses, 162 00:18:45,390 --> 00:18:47,700 as indeed many people haven't. 163 00:18:48,780 --> 00:18:56,819 But what I have done, um, was in some of those early things I talk about with those building projects, um, I have designed, 164 00:18:56,820 --> 00:19:05,450 commissioned and run containment laboratories for, um, dangerous pathogens for most of my career, which are, well, things like HIV, for example. 165 00:19:05,550 --> 00:19:11,160 No, I mean, sorry. Oh, containment, of course, is a place where you can safely work on nasty pathogens without them escaping. 166 00:19:11,220 --> 00:19:21,180 And imagine the sort of physical and procedural barriers you need to make sure that people don't take their work home with them accidentally. 167 00:19:21,630 --> 00:19:32,850 Um, so we were in a good position from that respect and it became very clear that nobody else in Oxford was in a particularly good position. 168 00:19:33,840 --> 00:19:38,010 Um, so we were the first to say, okay, right. 169 00:19:38,010 --> 00:19:44,360 Well, you're going to need some ability to work on real viruses. 170 00:19:44,460 --> 00:19:51,570 There's many experiments you can do that are useful in, in response to the pandemic that don't involve working on real infectious virus. 171 00:19:51,930 --> 00:19:58,500 And there were lots of labs doing that, but quite a few these lines of work like for example, the vaccine development stuff. 172 00:19:59,310 --> 00:20:03,230 If you don't have a test on real live virus, you can't proceed. 173 00:20:03,240 --> 00:20:10,319 And so that was what we were able to provide. It took quite a lot of, uh, well, a great deal of work for a few months. 174 00:20:10,320 --> 00:20:20,470 I think we were ready towards the end of March with a health and safety executive approval for working on SARS-CoV-2 and I and uh, 175 00:20:20,590 --> 00:20:26,360 uh, a research assistant called Becky Moore. I've interviewed her and interviewed her already, uh, 176 00:20:26,490 --> 00:20:31,500 did the lion's share of the work getting all that ready with lots of great support from our safety office, 177 00:20:31,500 --> 00:20:35,300 Tracey Muster and Safety Office and so she's on my list. A good I've got a date to talk to. 178 00:20:35,430 --> 00:20:41,460 Excellent. Excellent. Now, it was that there was, there was a lot of pulling together at that stage. 179 00:20:41,790 --> 00:20:46,949 I'm not sure that everybody around Becky and I, as it were in the department, 180 00:20:46,950 --> 00:20:52,559 generally understood quite how much work and is involved in putting this stuff together safely. 181 00:20:52,560 --> 00:20:55,320 But be that as it may, it came off. 182 00:20:55,920 --> 00:21:07,559 And of course, from around about Easter, the possibility of anybody in the department doing any work on anything else became minimal. 183 00:21:07,560 --> 00:21:21,180 So. So we were able to recruit to the call team, um, a bunch of, uh, 184 00:21:21,250 --> 00:21:26,530 graduate student postdocs that worked on other viruses and train them up to work on this. 185 00:21:26,560 --> 00:21:33,130 So after about three months, we, we were able to hand quite a lot of the experimental work on, onto, 186 00:21:33,200 --> 00:21:43,090 onto this team and um, and that was able to deliver for various, um, um, collaborating, uh, groups useful, um, 187 00:21:44,260 --> 00:21:49,570 useful analytical techniques, I guess the chief amongst which is something called the um, 188 00:21:50,050 --> 00:21:58,870 infectivity reduction neutralisation assay, which is basically a way of testing whether the, uh, antibodies present in a sample. 189 00:21:58,870 --> 00:22:05,889 It could be a human serum sample or it could be an experimental reagent with whether they are capable 190 00:22:05,890 --> 00:22:10,990 of preventing virus from infecting cells and quantifying how capable they were of doing that. 191 00:22:11,530 --> 00:22:15,250 Um, and did you need to use your stem cell technology? 192 00:22:15,490 --> 00:22:17,500 No, not for that. Not for that. No, not for that. 193 00:22:17,770 --> 00:22:27,250 We we have, um, I'll come onto that later because we have been using it for things that you otherwise can't do, which is a nice illustration. 194 00:22:27,610 --> 00:22:33,939 But for the standard neutralisation assays, there's a the world of virology is very conservative. 195 00:22:33,940 --> 00:22:39,010 And if we're very happy with a cell line called Villarosa, which comes from the African green monkey. 196 00:22:39,410 --> 00:22:46,600 Uh, um, uh, and if you're virus is able to grow in that cell, which this virus is, 197 00:22:47,740 --> 00:22:52,150 then people know what you're talking about when you say, I've done an infectivity assay in the cell line. 198 00:22:52,660 --> 00:22:59,260 Um, what we did have to develop so was a higher throughput method for doing that assay. 199 00:22:59,800 --> 00:23:11,080 Um, the assay we started with was the classic plaque assay, the, um, in exactly the form that was developed by James Porterfield back in the sixties. 200 00:23:11,080 --> 00:23:15,460 James Ford, who had been my mentor in virology and had done the school originally. 201 00:23:16,150 --> 00:23:23,830 Um, and it served us very well, but it wasn't terribly high throughput, so we could only assess the, uh, 202 00:23:23,830 --> 00:23:34,210 the neutralising power of a handful of reagents each week in order to, in that sort of assay because of the format. 203 00:23:34,820 --> 00:23:38,200 Um, so we were, we, we sat down and thought, well, 204 00:23:38,200 --> 00:23:46,870 can we make a higher throughput version looking at what other people had done in some other systems and with, um, uh, some, uh, 205 00:23:47,590 --> 00:23:54,540 reagents provided by Alan Townsend's group, uh, of particular, uh, 206 00:23:54,820 --> 00:24:05,650 human monoclonal antibodies which had been derived from patients in Taiwan and with some suggestions from Gavin's Cretans lab on, 207 00:24:06,220 --> 00:24:09,280 uh, work they had been doing already in dengue virus, 208 00:24:09,280 --> 00:24:16,820 we were able to develop what we call a micron neutralisation assay, which is about four times the throughput, um, 209 00:24:17,110 --> 00:24:22,800 in about a quarter of the times as a 16 times throughput, which enables us to, 210 00:24:22,860 --> 00:24:26,860 to screen a much larger number of things that is very technical and trivial sounding. 211 00:24:26,860 --> 00:24:35,380 But actually any of these things where you're wanting to see is something effect effective or not, you need to be able to test a lot of individuals. 212 00:24:35,680 --> 00:24:41,880 And so we were able to do that. So what were the kinds of question and well, actually ask another question first and then come back to that one. 213 00:24:42,430 --> 00:24:44,330 You used the word collaboration a little ago. 214 00:24:44,410 --> 00:24:52,389 Now you've talked about old and and so was there very much a sense of all the departments that were pulling together on this? 215 00:24:52,390 --> 00:24:55,540 And was that novel or have you always worked like that? Mm hmm. 216 00:24:56,290 --> 00:25:03,560 Um, I think for the first probably nine months, there was a unique sense of pulling together. 217 00:25:03,830 --> 00:25:09,760 I think after nine months, we went back to kind of normal levels of collaboration with a certain amount of competition as well. 218 00:25:10,330 --> 00:25:17,290 But for the for the first period, it was very, very clear, everybody setting aside everything just to make sure things happened. 219 00:25:17,740 --> 00:25:19,389 Um, so, for example, 220 00:25:19,390 --> 00:25:29,350 we hosted in our containment laboratory suite several other groups from other departments around Oxford until they had the capacity to, 221 00:25:29,350 --> 00:25:31,750 to, to, to do things themselves. 222 00:25:32,350 --> 00:25:43,870 Um, and yes, there was a very useful forum that Richard Cornell, uh, convened, which was weekly to start off with, um, of, 223 00:25:44,230 --> 00:25:52,630 of a round robin all on teams or zoom one on one together where all the people working in the relevant areas would report any, 224 00:25:52,990 --> 00:25:56,620 um, any progress or any challenges or what have you. 225 00:25:56,620 --> 00:26:01,749 And we shared a great deal of, of expertise and information and, and support that way. 226 00:26:01,750 --> 00:26:09,130 And that was, that was very, very valuable and quite, quite cheering that, that, that, that happened so readily. 227 00:26:09,610 --> 00:26:13,720 Um, obviously you can't keep up that level of intensive. 228 00:26:13,950 --> 00:26:17,190 Of of of networking for ever. 229 00:26:17,670 --> 00:26:30,480 Although I'd have to say that the the change is that the lockdown imposed restrictions on travel have been incredibly beneficial, in my view, 230 00:26:31,380 --> 00:26:38,220 in forcing us all around the world to use these systems like Zoom and teams more to have 231 00:26:38,220 --> 00:26:42,900 meetings quite often almost at the drop of a hat with people from all around the world. 232 00:26:42,900 --> 00:26:53,850 And that's very, very useful. So one particular one I'm on is a W.H.O., one that meets every month and shares experience and and technology and so on, 233 00:26:53,850 --> 00:26:55,919 all about these sort of diagnostic assays. 234 00:26:55,920 --> 00:27:02,800 And I was I was talking there and that wasn't happening before because you had to be in Washington to go to Geneva to, 235 00:27:02,930 --> 00:27:06,690 to be part of those sort of things. And I think that's great actually. 236 00:27:07,740 --> 00:27:10,830 Um. Yeah. So that's, that's good. 237 00:27:11,160 --> 00:27:20,490 Obviously, there's still a lot of collaboration. I mean, this, the, the projects that run through my own group as suppose sort of in the facility, um, 238 00:27:21,510 --> 00:27:25,800 with lots and lots of groups in my own group involve collaborations with um, 239 00:27:26,580 --> 00:27:34,229 several groups in MDM and at Harwell and in China and in Colorado and so on. 240 00:27:34,230 --> 00:27:40,049 So it's a highly collaborative thing, but that's only slightly more so than normal, as it were. 241 00:27:40,050 --> 00:27:46,140 At this point. They're generally two way or sweet way collaboration on focus particular projects. 242 00:27:47,390 --> 00:27:50,580 Um, so what were the urgent questions that needed answering? 243 00:27:50,640 --> 00:28:00,480 Yeah. So the, the, I guess the two, um, the two that we got involved in early on, the less famous of the two I'll, 244 00:28:00,600 --> 00:28:06,890 the most famous of the two, first of all, was a real challenge that they had in the, um, 245 00:28:07,020 --> 00:28:15,670 in the hospitals and the diagnostic branches of hospitals and knowing how safe it was to handle patient samples, um, 246 00:28:15,690 --> 00:28:25,740 because this virus isn't all that unusual, but in this virus, you can have samples that are positive for the presence of viral components. 247 00:28:27,240 --> 00:28:30,630 But should you be handing them as if they really are containing infectious virus? 248 00:28:30,870 --> 00:28:34,799 Because if you handle them like that, then you have to handle them in a facility like ours, 249 00:28:34,800 --> 00:28:38,580 which is incredibly constraining, and you can't run lots of diagnostic tests. 250 00:28:38,970 --> 00:28:51,270 So we helped them out in doing some systematic evaluations of such samples with different levels of evidence of, of uh, viral components in them, 251 00:28:51,930 --> 00:28:59,490 and were able to show that for the vast majority of them, unless you've got extremely high levels of viral components in there, 252 00:28:59,760 --> 00:29:08,819 what was their was not infectious, it was merely junk and could be handled under good laboratory practice conditions in 253 00:29:08,820 --> 00:29:12,930 the standard diagnostic lab which enabled them to these are mostly blood samples, 254 00:29:12,930 --> 00:29:20,280 blood samples and generally blood samples. And in fact, it's been very hard to find any infectious virus in things like blood. 255 00:29:21,090 --> 00:29:30,360 Yeah. Other than in upper respiratory tract secretions you can find you got plenty of evidence of viral components, lots of it in the gut. 256 00:29:30,360 --> 00:29:33,749 For example, very hard to isolate an infectious virus. 257 00:29:33,750 --> 00:29:37,110 We don't we still don't understand this. This has been a bit of a puzzle for a couple of years. 258 00:29:37,560 --> 00:29:46,290 Um, but, but the infectious virus is by and large, what's coming out in the aerosols from, from people's noses. 259 00:29:46,290 --> 00:29:49,590 And that's so that was helpful, I think. 260 00:29:50,190 --> 00:30:01,020 Um, and the second thing obviously was the, the famous face to, uh, clinical trial for what became the AstraZeneca vaccine where um, 261 00:30:01,770 --> 00:30:13,589 that the Oxford team had some results from a couple of collaborators outside Oxford on some early samples that they weren't very happy with. 262 00:30:13,590 --> 00:30:18,480 Uh, but there were reasons for not being happy with the results was sound. 263 00:30:18,810 --> 00:30:26,160 So they asked us if we do a comprehensive set of, of tests of uh, neutralising assays on these samples, which we did. 264 00:30:26,940 --> 00:30:38,819 Um, that was quite interesting experience in that, um, it didn't really strike me and the team when we started doing it, 265 00:30:38,820 --> 00:30:47,920 but we were at the point of being about to reveal the results is on the last, 266 00:30:48,270 --> 00:30:56,459 on the homestretch when we suddenly sort of realised um, this is quite a high um, consequence experiment. 267 00:30:56,460 --> 00:31:09,000 If what we discover is that the people that have had uh, the vaccine do not have neutralising antibodies at a sufficiently high titre in their blood, 268 00:31:09,660 --> 00:31:13,670 this is going to be a no go result, because there's no way of. 269 00:31:13,710 --> 00:31:16,590 Get permission to a large phase three trial. 270 00:31:17,070 --> 00:31:22,920 If you're not generating the thing that's known to be the protective thing, which is neutralising antibodies. 271 00:31:23,820 --> 00:31:30,990 Luckily we didn't know what the samples were. They were all under code, which is always a great relief actually when people send you stuff on a code. 272 00:31:31,470 --> 00:31:37,290 But we got, we got the answers that we sent back to the, uh, the gener uh, 273 00:31:37,320 --> 00:31:44,340 and they decoded them and analysed them and luckily it corroborated what they were hoping to see, 274 00:31:44,340 --> 00:31:47,490 which was, uh, that the, the, the, um, 275 00:31:48,390 --> 00:31:55,709 the adenoviral vectored vaccine was indeed able to elicit good neutralising responses in almost all participants. 276 00:31:55,710 --> 00:31:59,670 So yeah, that was, that was, that was good, good thing to have done. 277 00:31:59,910 --> 00:32:07,080 And we were able to round quickly and uh, and then the whole string of things after that of various monoclonal antibody reagents and, 278 00:32:07,080 --> 00:32:12,750 and aptamer reagents and nanobodies and chimeric proteins and all sorts of other things that I think we need to go into those. 279 00:32:13,070 --> 00:32:21,380 Well I'm happy to talk about this. Yes. So the point of those was the point of those to start thinking potentially about therapy. 280 00:32:21,390 --> 00:32:24,990 Absolute. Yes, yes. Yes. Therapy and and analysis, essentially. 281 00:32:24,990 --> 00:32:34,320 Yes. So, um, you'll be aware of monoclonal antibodies that are used in therapy, so the Regeneron antibodies and that sort of thing. 282 00:32:35,670 --> 00:32:45,389 Um, uh, but of course making antibodies is and infused image people's arms is, is not the sort of thing that you can do at the drop of a hat. 283 00:32:45,390 --> 00:32:56,790 So millions of people are in fact around the world. So the hunt has been on to try and find some better way of doing that. 284 00:32:57,120 --> 00:33:03,270 More, uh, that's either cheaper or more powerful or easier to administer. 285 00:33:04,290 --> 00:33:09,420 And actually more recently we'll come back to this stuff that you might do that you could keep on the shelf for future pandemics. 286 00:33:12,180 --> 00:33:21,330 And so collaborators of a variety of in a variety of places had their pet approaches to doing this. 287 00:33:21,360 --> 00:33:30,189 Um, I have my pet budget. I might talk about it in a moment. Um, uh, but we evaluate them all in the same system. 288 00:33:30,190 --> 00:33:32,909 This is quite critical to be able to evaluate them all against each other. 289 00:33:32,910 --> 00:33:43,799 So, um, uh, give you the simple example is, um, human antibodies derived from, for example, AIDS patients in Taiwan. 290 00:33:43,800 --> 00:33:47,430 And we were able to show which ones were neutralising, which ones weren't, 291 00:33:48,300 --> 00:33:55,950 which ones neutralised, um, what turned out to be, uh, variant, invariant bits of the virus. 292 00:33:55,950 --> 00:34:05,130 In other words, would they survive the changes that the viruses evolved over the course of the, of the pandemic in advance of concern? 293 00:34:06,390 --> 00:34:07,230 That's fairly simple. 294 00:34:07,230 --> 00:34:18,000 One and another reasonably simple one is make is, uh, colleagues, um, uh, making versions of the virus receptor, the ace2 receptor, 295 00:34:18,450 --> 00:34:28,650 um, usually fused to, um, the back end of an antibody molecule so that there is now a soluble but dimeric, um, version of itself. 296 00:34:29,400 --> 00:34:41,070 Um, and using this as a decoy essentially, uh, and what one, the advantage of that, um, would be that the virus has no where to evolve to with that. 297 00:34:41,070 --> 00:34:49,350 If the virus is no longer blocked by that, then the virus can presuming not interact with the same molecule on the host surface and infect cells. 298 00:34:49,350 --> 00:34:53,430 So that's a that's a bit of a clever block. 299 00:34:54,630 --> 00:35:01,290 The problem with that one has turned out to be that the level of potency isn't sufficiently high. 300 00:35:01,560 --> 00:35:04,950 So it's very, very resilient to change, but it's not very potent. 301 00:35:04,950 --> 00:35:08,729 And this is quite a case. It's it's catching some of the virus, but not enough. 302 00:35:08,730 --> 00:35:16,140 This it you have to have a very, very high concentration of your your inhibitor to be a be a good block, effective block. 303 00:35:16,350 --> 00:35:28,290 And that's a problem. And this has been quite a common thread that things that are potent, uh, are generally very sensitive to virus mutations. 304 00:35:28,290 --> 00:35:31,769 Things that are resilient to virus mutations tend to be not very potent. 305 00:35:31,770 --> 00:35:35,370 And that's been a, that's been a very common, not universal threat. 306 00:35:36,330 --> 00:35:37,170 But this is a yeah, 307 00:35:37,170 --> 00:35:47,360 I think there's a little bit of immunology we haven't quite tied down the when you say the things that are potent and are sensitive to mutations. 308 00:35:47,400 --> 00:35:56,309 Yes. Saying is that the you start off with a nice lock and key, but the virus works out how to rearrange itself a bit. 309 00:35:56,310 --> 00:35:59,430 Exactly. And particularly despite the spike protein. Yeah. 310 00:35:59,610 --> 00:36:05,309 Yeah. We if you'd like to dive into that a little bit, I'm very happy to talk about that because this is obviously quite a bit of what the the more 311 00:36:05,310 --> 00:36:08,910 basic stuff we've been doing has been trying to understand all these all these changes. 312 00:36:08,910 --> 00:36:13,620 So, yes, why this the spike is the is the surface protein of the. 313 00:36:13,680 --> 00:36:20,430 Virus, which the virus deploys to bind first to its receptors and then to fuse with the cells to gain entry. 314 00:36:22,380 --> 00:36:25,770 The spike of SARS-CoV-2 is Trimeric molecule. 315 00:36:25,770 --> 00:36:28,140 Like, um, like any corona virus. 316 00:36:28,680 --> 00:36:39,900 It has a couple of knobs on the surface of each component of that trimer, um, one of which is known to most people as the receptor binding domain. 317 00:36:40,140 --> 00:36:45,690 RBD And that is the bit that interacts with the ACE2 receptor. 318 00:36:46,230 --> 00:36:53,690 Um, uh, I think Alan Townsend came up with a very memorable picture of this one, which I like and I always use. 319 00:36:53,700 --> 00:37:00,030 So if you imagine the form of a little squirrel, cute little squirrel, just nibbling away at nuts like that on your lawn. 320 00:37:00,120 --> 00:37:06,090 And I think he was looking at his and doing all such things. That's what this RBD looks like. 321 00:37:06,690 --> 00:37:14,790 Yeah. Through a slight squint, um, when it's standing upright, but it is normally not standing upright is normally sleeping on its left hand side. 322 00:37:14,790 --> 00:37:23,640 So the three little squirrels all sleeping on the left hand side, and every so often one pops up and it's only in the pop up version that it can bind. 323 00:37:23,880 --> 00:37:27,990 So it sort of is, and back to the ace2, uh, molecule. 324 00:37:28,980 --> 00:37:35,040 And then once that's happened, it's stuck in there, it's locked if you like, and then the other ones can pop up as well. 325 00:37:35,040 --> 00:37:42,690 And once to have popped up and they're locked, then the third one almost inevitably goes in fusion reaction takes place, right? 326 00:37:43,830 --> 00:37:50,580 So the bits of the squirrel, the sort of back of the head and the back that interact with a tune, 327 00:37:51,330 --> 00:37:56,070 um, have to be pretty invariant, otherwise it can't bind to waste to any longer. 328 00:37:56,820 --> 00:38:08,460 And in principle, those are good sites for antibodies to bind because if an antibody binds to their, then it should be resistant to mutation. 329 00:38:09,270 --> 00:38:18,599 That hasn't actually proved to be the case generally because many of the variants of concern have found 330 00:38:18,600 --> 00:38:25,230 mutations that manage to preserve the Ace2 interaction but disrupt the most common antibody interactions. 331 00:38:26,370 --> 00:38:31,709 And was that a puzzle? When you say it was a puzzle for people until until a lot of the structural biologists, 332 00:38:31,710 --> 00:38:41,940 people like Dave Stewart and folks in the US and everywhere else start to actually work out exactly how these things are binding. 333 00:38:42,420 --> 00:38:47,490 But it just shows you how multi clever viruses as it shows you how clever Darwin is, you know, just. 334 00:38:47,790 --> 00:38:59,280 Yeah. And of course. The fact that out there with millions of people, viruses being exposed to human antibody all the time, 335 00:38:59,700 --> 00:39:05,550 there's a very strong selection pressure for viruses to evolve, resistance to antibodies. 336 00:39:06,450 --> 00:39:14,310 So I maintain their ability to bind ways to so the numbers are against us in that respect. 337 00:39:14,910 --> 00:39:20,340 Now, recently there have been a couple of reports of monoclonal antibodies, 338 00:39:20,340 --> 00:39:27,030 very rare ones binding to sites on the squirrel, which generally at the squirrel's lair, 339 00:39:27,030 --> 00:39:34,259 if I can put it that in a delicate, uh, delicate way, which overlap with the bit by so ace2, 340 00:39:34,260 --> 00:39:38,459 but only slightly but are very, very conserved between all these various control. 341 00:39:38,460 --> 00:39:42,450 And those are potentially more, more powerful therapeutics. 342 00:39:43,830 --> 00:39:51,180 So yes, so I'm indicating that all of the use when you trust the antibodies, bind to the squirrel on top is not quite true. 343 00:39:51,190 --> 00:39:57,299 There are antibodies to bind. For example, down on the flanks of the squirrel that neutralise. 344 00:39:57,300 --> 00:40:05,250 But generally they don't neutralise as well, but they often more resistant to mutation because this is not so subject to selection. 345 00:40:05,550 --> 00:40:14,070 There are indeed sites further down the spike that are able to be bound by antibodies that can utilise mice, 346 00:40:14,070 --> 00:40:17,520 but they're much rarer to find those antibodies. 347 00:40:18,060 --> 00:40:22,920 They didn't come up as often. But it's that squirrel. 348 00:40:23,760 --> 00:40:29,730 It's very good image, isn't it, in um, uh, the Swedish. 349 00:40:29,740 --> 00:40:34,680 So, so the question then is can we find clever alternative ways to regular antibodies to, 350 00:40:35,370 --> 00:40:40,800 to, um, to, to, to neutralise spike by binding to the right bits of squirrel. 351 00:40:42,450 --> 00:40:45,450 Um, uh, sounds like Friday night tennis, doesn't it? 352 00:40:45,450 --> 00:40:55,650 Nice bit of squirrel. Um, so the ace2 dimer was obviously one one way, but just not, uh, uh, potent enough. 353 00:40:56,130 --> 00:41:07,500 Um, colleagues in, uh, in, in Zhuhai, in, um, in, in China near Hong Kong, um, uh, ex Dan School, um, 354 00:41:07,920 --> 00:41:14,250 came up with a chimeric version which had an ace two component and an antibody component in one molecule. 355 00:41:14,700 --> 00:41:22,950 Uh, the idea of there being I bind two different sites on the spike, uh, uh, I can triangulate the virus and give it know where to go. 356 00:41:23,190 --> 00:41:28,920 We published that one and it did indeed neutralise, but that hasn't gone into clinical trial. 357 00:41:30,250 --> 00:41:38,280 Um, uh, colleagues at the Rosalind Franklin Institute, um, uh, to nanobodies. 358 00:41:38,670 --> 00:41:45,690 Uh, so these are from llamas which aren't, but which are like our regular antibodies. 359 00:41:45,690 --> 00:41:50,850 But they have a, just a single domain as opposed to double domain binding to the antigen. 360 00:41:51,270 --> 00:41:58,979 Uh, which has some advantages. And so we were able to help them find, identify which ones were neutralising their very powerfully. 361 00:41:58,980 --> 00:42:07,470 Interestingly, we published quite a few papers on those now I think, and it's those that are the subject of a Wellcome Trust collaborative program 362 00:42:08,910 --> 00:42:17,040 for finding such molecules that would target multiple different viruses that, 363 00:42:17,340 --> 00:42:22,200 you know, disease X the the next ones that might breakthrough and to have not just multiple 364 00:42:22,200 --> 00:42:25,439 distant coronaviruses but not well we could start with the Corona virus, 365 00:42:25,440 --> 00:42:28,020 but we're also interested in Nipah virus and other things as well. 366 00:42:28,830 --> 00:42:40,260 Um, so the challenge there is to see if we can, if we can make such things, if they can be good, resilient, cheap, storable, almost. 367 00:42:40,380 --> 00:42:45,660 So that gives you a first line of attack when a new pandemic starts. 368 00:42:45,840 --> 00:42:49,140 So what do you call that to that? It's not it's not exactly a vaccine. 369 00:42:49,230 --> 00:42:55,709 No, it's not a vaccine. It's was it's almost like passive immunisation, which is it used to be a thing, but it's not with antibody, 370 00:42:55,710 --> 00:43:00,790 but it's this is the equivalent of that is prophylactically using that that the, 371 00:43:00,810 --> 00:43:09,810 uh, um uh a antibody like but you would, you would inject it in advance of a exhort the academic colleagues other than to patients. 372 00:43:09,840 --> 00:43:17,610 Exactly. And it would give you in that window before even though we've got accelerated vaccine development, there's that period isn't there. 373 00:43:19,470 --> 00:43:22,080 Even if that period is much shorter than we ever thought it could be, 374 00:43:22,500 --> 00:43:30,960 it's nine months or something that was in that first six months or so to have something that you could use just to slow the wretched thing down. 375 00:43:31,140 --> 00:43:40,170 Other than telling people to stay indoors. So that's, that's the idea behind that sort of approach. 376 00:43:41,070 --> 00:43:48,060 Um, of course having to inject something is, as we indicated earlier, not ideal. 377 00:43:48,690 --> 00:43:52,500 Um, you'd really rather have something that I think is a. 378 00:43:52,590 --> 00:44:00,210 Hill or more easily to envisage take in the form of a Zoom inhaler or something like that. 379 00:44:00,420 --> 00:44:04,710 It didn't require medical interventions and so on. 380 00:44:05,490 --> 00:44:14,490 So we've also been working with um, uh, a company in Colorado on a different approach. 381 00:44:14,940 --> 00:44:19,139 And this is making what's called abstinence, which is a completely different sort of chemistry to, 382 00:44:19,140 --> 00:44:24,180 to any of the antibodies or nanobodies or chimeric proteins that I've been speaking about, 383 00:44:24,830 --> 00:44:37,170 uh, but have similar properties in that they, they are, you can isolate, um, atoms and they are the bits of protein. 384 00:44:37,170 --> 00:44:42,510 They know they're nucleic acids, they're modified, they're non-natural nucleic acid. 385 00:44:43,140 --> 00:44:46,350 And the beauty of them is it's really hard to describe this. 386 00:44:47,100 --> 00:44:50,250 Does this have to be good for a generalist audience generally? 387 00:47:09,250 --> 00:47:17,350 Um, and so at the they were in the same position as any lab in the UK was that they 388 00:47:17,350 --> 00:47:21,790 were told they couldn't do their usual stuff at the beginning of the pandemic, 389 00:47:22,180 --> 00:47:26,260 but if they had any SARS-CoV-2 projects, they could go in and do that. 390 00:47:26,920 --> 00:47:35,709 So I approached them and said, Why don't we do this thing like we did for HIV before and make an app to as to the cells, the surface protein of cells. 391 00:47:35,710 --> 00:47:39,760 CO two And you guys are the best in the world at doing that. 392 00:47:39,910 --> 00:47:43,809 After the selection and leave, they jumped at it. And so, so we did that. 393 00:47:43,810 --> 00:47:47,110 And the paper's not out yet. I hope it'll come out soon. 394 00:47:47,760 --> 00:48:02,260 Um, but we were able to find some, uh, extraordinarily powerful, very small actors that neutralise more potently than any antibody we've yet found. 395 00:48:02,770 --> 00:48:07,210 Neutralises monomers. Not that you don't have to have them as dimers. That's something you can come back to if you like. 396 00:48:07,830 --> 00:48:16,300 Um, and a very, very much cheaper and more robust and completely resilient to all the variants we've yet seen in the virus. 397 00:48:16,630 --> 00:48:20,500 And they bind in the rear of the squirrel as well. 398 00:48:21,250 --> 00:48:24,700 Um, so you've done the neutralising, I've done the neutralisation stuff. 399 00:48:24,700 --> 00:48:31,570 And, and, and Jan in turn in Alan's lab has done the competition, realises to show that their binding to the rear of the squirrel. 400 00:48:33,340 --> 00:48:38,930 Um, so those chemicals are as cheap as chips to make. 401 00:48:39,310 --> 00:48:45,850 Um, the. There's been a real revolution. Well, of course you've come across the, the RNA vaccine stuff. 402 00:48:46,840 --> 00:48:50,559 Nucleic acid like that can be made on a vast scale, really cheap. 403 00:48:50,560 --> 00:48:55,180 In fact, these ones can be made even more cheaply than that on a large scale. 404 00:48:55,930 --> 00:49:04,180 And because they're not proteins, um, because then so nucleic acids, they are, they're very much more stable. 405 00:49:04,180 --> 00:49:10,870 You can, you can leave them in a solution at room temperature for weeks and weeks and weeks and they just don't degrade. 406 00:49:10,870 --> 00:49:15,190 You can leave them as a dry powder in a vial on a shelf, even in a tropical country. 407 00:49:15,460 --> 00:49:19,330 And they will stay perfectly open to the time where you need to reconstitute them. 408 00:49:19,690 --> 00:49:29,680 So we hope where we're hoping to go. And uh, actually, um, this isn't breaking confidence, but the Gates Foundation has asked us to, 409 00:49:29,710 --> 00:49:39,700 to pursue this is to formulate these things in a clinically useful way in, for example, inhalers. 410 00:49:39,700 --> 00:49:48,910 And so to to try and get them to the point where we could have them sitting on shelves, formulated off the shelves so they can be sold the boots. 411 00:49:49,330 --> 00:49:56,630 Yeah. And you can imagine I think much more easily going to your, um, your bathroom cabinet once a day, 412 00:49:56,680 --> 00:50:03,400 taking a puff of your inhaler to protect your upper respiratory tract for the rest of the day. 413 00:50:03,520 --> 00:50:08,440 Then you can going in once a week and having an infusion of antibody in your in your arm. 414 00:50:09,520 --> 00:50:13,020 So that's the idea with those. And I think as we did clinics. 415 00:50:13,170 --> 00:50:18,130 Mm hmm. Yeah. Thanks. I think I've got I've got to excited that I'm sorry. 416 00:50:18,460 --> 00:50:23,170 Of, of, of the crisis. So is that the thing that you said earlier? 417 00:50:23,170 --> 00:50:26,320 It was the thing that you were excited about that you were going to talk about later? 418 00:50:26,800 --> 00:50:30,430 Sorry. It probably was. It probably was. 419 00:50:30,460 --> 00:50:36,310 Uh, yeah. So the other thing you mentioned you were going to come back to later was ways of using the stem cells. 420 00:50:36,400 --> 00:50:44,870 Oh, yes, yes. And this is where we get to more of the biological side of the virus. 421 00:50:44,870 --> 00:50:48,990 So obviously, um, we can study how virus infects us. 422 00:50:49,210 --> 00:50:55,120 Model cell lung like a virus cell. But it's, it's in principle entirely possible, 423 00:50:55,150 --> 00:51:01,090 more than possible that the consequences of virus infecting virus so different from the consequences of virus infecting a, 424 00:51:01,090 --> 00:51:03,940 uh, human respiratory epithelial cell. 425 00:51:04,270 --> 00:51:09,280 If anything else, the reason why we have various cells is and why they're so useful is they have no interference system. 426 00:51:10,450 --> 00:51:18,790 So whereas you do y so the closer you can get to a cell that's like the cell of your respiratory epithelium, the better. 427 00:51:19,870 --> 00:51:28,480 And up till now, the only source of such cells has been biopsies from people's bronchi. 428 00:51:29,170 --> 00:51:34,239 And these are available, but only very small quantities and and and not routinely. 429 00:51:34,240 --> 00:51:39,610 And of course, every donor has a different genetic background and small quantities. 430 00:51:39,970 --> 00:51:47,709 So what we've done, we didn't invent these methods, we're trying to improve on them is use the methods of pluripotent stem cell differentiation 431 00:51:47,710 --> 00:51:53,290 in vitro with and we succeeded in doing that to generate a respiratory epithelia. 432 00:51:55,000 --> 00:51:58,120 So these are the cells that line your windpipe exactly. 433 00:51:58,210 --> 00:52:03,430 When in fact there are two there are two major classes of these and I've learnt a lot since I've been doing this. 434 00:52:03,430 --> 00:52:08,800 I knew nothing about these sorts of cells at all before the cells that line your airway. 435 00:52:08,810 --> 00:52:13,000 These are ciliated is a ciliated epithelium. 436 00:52:13,070 --> 00:52:21,770 But this is a little here's the wave activity ways and so that's so the cells that have those waving pores, if you like, 437 00:52:22,190 --> 00:52:31,879 and cells that secrete mucus and what they're doing between them is is covering your that upper respiratory 438 00:52:31,880 --> 00:52:36,050 epithelium with a layer of mucus which traps things that you don't want to get into your lungs. 439 00:52:36,380 --> 00:52:39,830 And there's what's called the mucus ciliary escalator. 440 00:52:40,070 --> 00:52:42,590 Which way washes it up, up, up. 441 00:52:42,590 --> 00:52:48,440 Your response to treat until it gets to your swallowing bit where you swallow down your stomach and it gets all destroyed, 442 00:52:48,440 --> 00:52:55,540 all the mosaic is destroyed. And that's quite a complicated epithelium, but we can just about make that nowadays. 443 00:52:55,790 --> 00:53:00,740 Um, and that's where many of the viruses like to replicate. 444 00:53:01,400 --> 00:53:06,080 But there's another epithelium which is on the lining of the air sacs and varies by surface area. 445 00:53:06,080 --> 00:53:07,880 If you spread it is much more of that. 446 00:53:10,400 --> 00:53:16,670 The alveoli, the alveolar, obviously the more I've learned about them, the more amazing I find them to be as well. 447 00:53:17,060 --> 00:53:19,160 So they don't really have very, very thin cells. 448 00:53:19,200 --> 00:53:30,380 Type one side is a very, very thin cell which forms the the wall of this layer sac and allows gas exchange with between the air on the inside, 449 00:53:30,390 --> 00:53:38,420 the wireless and the contents of the blood on the other side. They are maintained by two other cells in them. 450 00:53:38,780 --> 00:53:43,730 So there's a type to numerous site which is the parent of the type one. 451 00:53:43,740 --> 00:53:48,890 So type one is like the in differentiated cell and they have a limited life and then they're gone. 452 00:53:49,740 --> 00:53:59,390 The type two is the tissue specific stem cell, which divides makes more type one tumour sites and also has various other functions like pumping, 453 00:53:59,930 --> 00:54:11,299 like any liquid that leaks into the virus back into the bloodstream. Um, so we can make those as well there they come in the differentiation pathway. 454 00:54:11,300 --> 00:54:18,350 They, uh, they're similar up to a certain point and then they, then they diverge so we can make both of these types of epithelia. 455 00:54:18,860 --> 00:54:27,800 And what's quite interesting is that different variants of different severity of virus infect preferentially one or the other. 456 00:54:28,490 --> 00:54:33,980 So most of your unpleasant symptoms come from if viruses managed to infect your RV only, 457 00:54:34,730 --> 00:54:40,760 whereas viruses that don't do that very well but managed to infect the upper respiratory tract are generally nicely transmissible, 458 00:54:40,760 --> 00:54:48,050 but not generally quite so dangerous. So your really serious diseases generally are lung diseases in the alveoli. 459 00:54:48,890 --> 00:54:56,360 So we've been able to do that and uh, the virus does what you'd hope it would do and was true for flu virus. 460 00:54:56,360 --> 00:55:01,700 We knew from others before it will replicate only infects cells from the surface, 461 00:55:01,700 --> 00:55:05,989 the apical surface, as opposed to the basso lateral surface from the other side. 462 00:55:05,990 --> 00:55:09,890 So the apical service is into the airway and the basement was into rest of the body. 463 00:55:10,910 --> 00:55:16,460 The virus infects itself, that side replicates, exits, just the same side goes out the way it came in. 464 00:55:17,030 --> 00:55:21,679 So they really do behave like the cells of your have your body. 465 00:55:21,680 --> 00:55:32,030 So we're trying to study the infection pathway in these cells and we've identified, um, a, uh, um, a, 466 00:55:33,140 --> 00:55:39,680 an enzyme controller of the traffic is normally present in these cells that controls 467 00:55:39,680 --> 00:55:43,010 the traffic of all the vehicles in and out of various compartments in the cell, 468 00:55:43,370 --> 00:55:48,649 which if you modify its activity, modify as far as replication very considerably. 469 00:55:48,650 --> 00:55:57,979 So we think we might be on the the early stages of identifying a new therapeutic target for response to infections. 470 00:55:57,980 --> 00:56:00,740 But there's a long way to go yet, but you can only do it in these sorts of cells. 471 00:56:01,250 --> 00:56:05,570 You can't do it in a undifferentiated pack of jelly like a virus cell. 472 00:56:07,010 --> 00:56:15,589 And the second thing that we're interested there is in how the biology of these cells is affected by the presence of the macrophages, 473 00:56:15,590 --> 00:56:23,450 which are also present in these tissues. So obviously there's the alveolar macrophage and there's an interstitial macrophage in the upper airways. 474 00:56:24,050 --> 00:56:32,120 And we know already from work we've done, others have done that the macrophages are very, very resistant to being productively infected by virus. 475 00:56:32,120 --> 00:56:36,530 They'll take up virus, but they really won't be producing any measurable amount of virus. 476 00:56:37,220 --> 00:56:43,620 What we don't yet know is. With their presence at the same time as these very susceptible cells, 477 00:56:44,010 --> 00:56:49,730 do they pass on the infection to these susceptible cells or do they protect their cells or what happens? 478 00:56:49,740 --> 00:56:53,130 And that's the that's the other big area of interest in our lab. 479 00:56:53,500 --> 00:57:02,829 Mm hmm. Yeah. So, I mean, I suppose when all this started, the level of knowledge of SARS-CoV-2 was just very, very low. 480 00:57:02,830 --> 00:57:06,180 I so you have to find out pretty much everything. Yeah. Yes. 481 00:57:06,360 --> 00:57:11,099 And it's it's it's been the case, I think, in science generally, 482 00:57:11,100 --> 00:57:17,910 that if there's a lot of attention on one in box virus, you get to find out a lot about it. 483 00:57:18,210 --> 00:57:23,070 Whereas if there's a rather obscure virus like frankly, the other coronaviruses were rather uninteresting. 484 00:57:23,070 --> 00:57:30,180 They didn't kill people, you know, we didn't know them about them before we get them that fresh. 485 00:57:30,180 --> 00:57:36,629 This flu is very often a corona virus, you know, the one that regulates clockwork sometime in the early Michaelmas term. 486 00:57:36,630 --> 00:57:41,970 I catch from my new students. Um, but it's not very serious. 487 00:57:42,750 --> 00:57:48,450 Uh, whereas this one was it. So a lot of lot of people around the world, thousands of researchers have been working on this, 488 00:57:48,450 --> 00:57:52,020 and we're finding out a great deal more than ever we knew before, which is a good thing. 489 00:57:52,050 --> 00:57:57,540 I think it was the same with HIV. People had a lot more HIV than we've known about retroviruses before. 490 00:57:57,540 --> 00:58:01,710 So that is, of course, the frustrating thing. 491 00:58:02,220 --> 00:58:09,570 The other flipside of that is highly competitive areas like that with lots of work and there's only a certain number of obvious questions to work on. 492 00:58:09,570 --> 00:58:18,150 So you get scooped quite often. Um, I'm old enough not to worry so much, but of course that does matter to the students postdocs. 493 00:58:18,360 --> 00:58:23,310 And you've got a pretty big team. Yeah, I suppose we are about 12 people at the moment. 494 00:58:23,620 --> 00:58:29,340 Well, it's not. It's not. It's not. It's not massive. Then what you'll, what you'll see on many of the papers is highly collaborative. 495 00:58:29,820 --> 00:58:34,980 Oh yes. No, I project pictures on the website. Maybe this I haven't gone to the recent. 496 00:58:35,580 --> 00:58:37,450 Um, it's quite a influx office. 497 00:58:37,600 --> 00:58:47,380 The average group member I should, I should check this properly but you know three years is a normal sort of peer of somebody being lab and, 498 00:58:47,420 --> 00:58:50,700 and quite often a bit less, um, occasionally a little bit longer. 499 00:58:51,240 --> 00:58:58,230 Um, so they turnover quite rapidly and getting grants and not getting grants and all that sort of stuff affects the dynamics. 500 00:58:58,500 --> 00:59:04,860 But yes, the authors of the papers are enormous. I mean, that's, that's been an eye opener, something I'm a little bit well, I don't know. 501 00:59:04,860 --> 00:59:14,070 It's a cultural difference, I think. Um, so in a, in a, in a regular non-clinical science paper, you will, 502 00:59:14,550 --> 00:59:22,170 you'll normally have one or two people who've done most of the hands on experimental stuff and they'll be at the front in the biological sciences. 503 00:59:22,170 --> 00:59:29,330 They'll be the front end of the author list. And you'll generally have one person who is the supervisor of them, and you might get an extra person. 504 00:59:29,370 --> 00:59:33,420 That was me. And that would be a normal size of of author list. 505 00:59:35,400 --> 00:59:43,140 In these multicenter studies, of course, you have for every cent you've got at least one principal investigator. 506 00:59:44,130 --> 00:59:47,850 So the back end of this string is, is really quite large. 507 00:59:48,750 --> 00:59:52,200 And then you've got a lot of people doing the individual experiments. 508 00:59:52,200 --> 00:59:55,529 If you imagine one of our neutralisation assays will very often take three 509 00:59:55,530 --> 00:59:59,520 or four people hands on just to do that neutralisation batch of experiments. 510 00:59:59,700 --> 01:00:05,540 So that's a lot of people to put in there when these are collaborative trial, uh, 511 01:00:05,550 --> 01:00:16,200 collaborative pieces of work with clinicians and, and also there's a vast number of players, all of whom. 512 01:00:19,660 --> 01:00:21,520 Tend to become horses one way or another. 513 01:00:21,970 --> 01:00:30,130 But it becomes, I think, one of our papers, like 60 or 70 or something like that, many of whom I don't even know or actually what they did. 514 01:00:31,700 --> 01:00:38,169 Um, and I think there is a bit of a tendency to have people on there just because they held a tube once or something like that. 515 01:00:38,170 --> 01:00:47,260 But then they're somewhere hidden in the middle. Um, so it is, but it's, it's, it's a very, very different sort of social dynamic. 516 01:00:47,620 --> 01:00:52,899 Um, not one I'm entirely comfortable with because it, on the one hand you say, well, just, 517 01:00:52,900 --> 01:01:01,420 just add blogs on because I'm sure, I'm sure, I'm sure he was, it was useful, but from a scientific integrity point of view. 518 01:01:03,010 --> 01:01:08,320 So I just follow the tone. I think it's important if your name is on a paper that you can answer for the paper. 519 01:01:08,890 --> 01:01:11,890 Yeah. And you can, you can say, well, what did I do? 520 01:01:11,890 --> 01:01:18,549 And can I just, uh, vouch for the reliability of the information that I'm responsible for in the paper? 521 01:01:18,550 --> 01:01:21,360 And ideally, I can make the whole thing, whole thing in one way, 522 01:01:21,450 --> 01:01:26,200 because I was present at the times when the raw data was discussed and analysed and when I said, 523 01:01:26,200 --> 01:01:31,400 Well, that's becomes impossible with these large teams. And so you can't really hold everybody you can. 524 01:01:31,420 --> 01:01:37,420 But I think people recognise that anyway. It's a small number of people at the back end are responsible for everything. 525 01:01:39,440 --> 01:01:43,370 So I mean, we're now it's August 20, 22. 526 01:01:44,270 --> 01:01:47,000 Well over two years since all this started. 527 01:01:47,360 --> 01:01:53,090 But it sounds as though you've got a number of lines of research that started because of the pandemic that is still very much going, 528 01:01:53,540 --> 01:01:54,740 you see right now. 529 01:01:55,860 --> 01:02:07,310 So, yes, in 2020 until the autumn, I suppose, I was very much in the mode of, well, I've put my work on hold, I'm doing the service work. 530 01:02:08,030 --> 01:02:13,229 Yeah. Because that's what the urgent takes priority over the important as it were. 531 01:02:13,230 --> 01:02:21,650 Yeah. Uh, I came to the realisation last year that not only were there some lines of work coming out of what 532 01:02:21,650 --> 01:02:26,330 we were doing that were actually scientifically interesting and but I would want to see through, 533 01:02:26,870 --> 01:02:30,560 but also that because of my advanced years, 534 01:02:31,730 --> 01:02:44,040 the effort involved in restarting the complex HIV latency microbial model stuff was to basically starting from scratch again with nobody, 535 01:02:44,040 --> 01:02:53,449 with any experience. There was too much involved in getting that going again for it to be realistic in the remaining chunk of my period. 536 01:02:53,450 --> 01:02:57,420 So I've kind of reconciled myself to not doing any more HIV work. 537 01:02:58,190 --> 01:03:03,110 So, um, the, the SARS-CoV-2 work carries on, 538 01:03:03,110 --> 01:03:09,410 including the very applied stuff like the emptiness and nanobodies stuff and the very basic stuff about the, 539 01:03:09,650 --> 01:03:12,980 the infection pathways and the defence by macrophages. 540 01:03:13,760 --> 01:03:21,380 And I think that's, that's all good. That's interesting. Um, and people are getting papers out of it and it's, and it's a good contribution. 541 01:03:21,770 --> 01:03:27,440 The neuroinflammation stuff is now restarted and that's back running. 542 01:03:27,440 --> 01:03:31,280 So that's relatively unchanged. Big thing that's changed. 543 01:03:31,280 --> 01:03:35,810 So my research direction has changed. Um, and I'm reconciled to that. 544 01:03:36,740 --> 01:03:45,380 The big thing that changed and I was really, really worried it wasn't in a healthy place was the research culture, the lab culture. 545 01:03:46,130 --> 01:03:52,100 And I said there's real upsides to the whole, um, ability to do things remotely. 546 01:03:52,670 --> 01:03:59,600 There are huge upsides. Communications across the globe have been much more facilitated by this. 547 01:04:01,460 --> 01:04:05,390 But a lab, at least a wet lab of sort. We are. We're not a theoretical lab. 548 01:04:07,620 --> 01:04:14,890 Does rely on accidental encounters between students, postdocs, technicians and peers on a day to day basis. 549 01:04:14,920 --> 01:04:18,360 Oh, how do you do it? What's gone wrong here? All that sort of stuff. 550 01:04:18,810 --> 01:04:22,590 And because for 18 months and more, 551 01:04:22,590 --> 01:04:27,120 we were under strict instructions only to come to the lab as briefly as possible to do the 552 01:04:27,120 --> 01:04:30,330 things that can only be done in the lab and to do as much as we could back in our homes. 553 01:04:30,870 --> 01:04:38,070 That culture really rather went away, and it was long enough to be the majority of a cycle of most of the people in the lab. 554 01:04:38,300 --> 01:04:43,620 Yeah. And so I was really, really worried when we started to ease the restrictions eased. 555 01:04:43,620 --> 01:04:48,510 The people weren't just coming back spontaneously. Then they'd find they could indeed do stuff with them. 556 01:04:48,550 --> 01:04:57,210 In fact, I've changed my pattern, so I will often work one or two days a week at home on things like my lectures or what have you, 557 01:04:59,550 --> 01:05:03,360 which I would never have thought about doing before, but never crossed my mind. 558 01:05:03,630 --> 01:05:07,620 So I can't blame the lab members for doing something similar, I suppose, 559 01:05:08,400 --> 01:05:16,770 but it has come back largely and the café is now buzzing again in the department, which is really because it was. 560 01:05:17,160 --> 01:05:22,940 That's pretty grim when it's just tumbleweed in the cafe. Just the department wasn't working then, but it is again. 561 01:05:23,040 --> 01:05:27,240 So I'm really I'm quietly optimistic, really. 562 01:05:27,270 --> 01:05:30,450 That sounds like a good balance because yes, there are certain kinds of work, 563 01:05:30,450 --> 01:05:34,200 but it actually is much easier to get done if you can totally focus at home. Absolutely. 564 01:05:34,320 --> 01:05:37,610 That's why my colleagues used to come in here to do some quiet work. Yes. Yes. 565 01:05:37,780 --> 01:05:42,509 So, yeah. Where my colleagues were at the moment. Because. 566 01:05:42,510 --> 01:05:44,220 Yes, because there's exactly. 567 01:05:44,230 --> 01:05:50,690 First for something where your work is, you know, if you're trying to get the words just right and framing arguments and something like that, 568 01:05:50,700 --> 01:05:55,019 if it's that sort of thing or you're trying to do a piece of deep analysis being 569 01:05:55,020 --> 01:05:59,280 interrupted every 10 minutes by somebody has to pass your office door isn't great, 570 01:05:59,280 --> 01:06:04,379 is it? Lose your friend. So, yeah, I agree with you. 571 01:06:04,380 --> 01:06:06,480 I think it's I think it's in a healthy place. 572 01:06:07,470 --> 01:06:11,549 And we have to think about using our labs differently than on, say, the place you're spending your whole time. 573 01:06:11,550 --> 01:06:22,630 So maybe more and more people can be members of the labs and the bench space seems to dictate hot desking, hot dog benches. 574 01:06:22,650 --> 01:06:32,160 We have we have started we because we moved lab um uh oh almost a year ago now and we decided to do it hot benching. 575 01:06:33,270 --> 01:06:41,870 Um, it sort of works. It sort of works and it's quite good because it stops the members of the lab from being messy. 576 01:06:41,880 --> 01:06:46,770 So they have to clear up each time. And that's good for safety and for all sorts of reasons. 577 01:06:49,060 --> 01:06:54,390 I can't remember if you said you still had any responsibility for undergraduate teaching, but that must have been something that. 578 01:06:54,400 --> 01:06:59,040 Oh, yes, the teaching changes. No, I had no, really. 579 01:06:59,080 --> 01:07:05,710 I've been on sabbatical this year, proper old conventional sabbatical, and I haven't been doing college teaching or, 580 01:07:06,430 --> 01:07:09,790 uh, university teaching this 12 month period just about to come to an end. 581 01:07:10,270 --> 01:07:18,010 But no, I threw out the, the peak time I was doing my full tutorial stint as well as everything else. 582 01:07:18,400 --> 01:07:23,410 Um, and, uh, yes, actually, almost in almost all respects. 583 01:07:23,410 --> 01:07:27,549 I enjoy the teaching. So because to be honest, in Oxford we don't get overburdened. 584 01:07:27,550 --> 01:07:32,770 And I know people do complain a lot, but, you know, it's not the same as 40 hour teaching week in some institutions. 585 01:07:32,890 --> 01:07:36,790 But you were doing it on zero teams. I was doing it on, on, on teams. 586 01:07:37,010 --> 01:07:48,160 Um, there was an interesting so this interest me at least one of my students come in, I think it was in his first year, uh, before the pandemic. 587 01:07:49,630 --> 01:07:53,920 This is in their first Michaelmas term in 2019. 588 01:07:54,620 --> 01:07:57,910 Uh, got mumps and so had to go home. 589 01:07:58,540 --> 01:08:09,580 So teams was available. And so we started doing tutorials with teams so that this student could be part of the tutorial group. 590 01:08:09,970 --> 01:08:12,010 And we just kept actually the things you can do in, 591 01:08:12,610 --> 01:08:18,729 in the team's environment that are hard to do in the physical tutorial surprised me once, once, once you know each other. 592 01:08:18,730 --> 01:08:26,080 I think that's that's the key thing. So we were in a good position to carry on doing our teachers, our teams, and that actually worked extremely well. 593 01:08:26,440 --> 01:08:36,540 Um, and lectures. It liberated the lectures. Uh, so our final lectures I run a, um, a theme on them emerging infections. 594 01:08:36,850 --> 01:08:46,540 Um, and I was able to, because we weren't gonna have any physical lectures then it liberates you from the 50 minute timetable of, of a didactic slot. 595 01:08:46,540 --> 01:08:51,430 You know, you can break it up into whatever length of piece is needed for that piece of intellectual stuff. 596 01:08:51,700 --> 01:08:57,370 And you can do more interactive things and you can get people willing to give you 7 minutes 597 01:08:57,370 --> 01:09:02,950 of interview online and record it from from Sydney or from Beijing or what have you. 598 01:09:03,550 --> 01:09:11,200 So it gave us a lot more, a lot better set of experiences for the students, frankly. 599 01:09:11,710 --> 01:09:21,610 Um, and I've yet to meet a student who says, given the choice, they would rather have only in-person rather than only pre-recorded lectures. 600 01:09:21,850 --> 01:09:25,360 They quite liked having the opportunity both. But so they were they were pre-recorded. 601 01:09:25,360 --> 01:09:30,249 We weren't doing them live over. No, the exactly the lectures were pre-recorded. 602 01:09:30,250 --> 01:09:39,400 We were doing some live seminar things where the students got lots of questions, but those carried on in the chat box afterwards anyway. 603 01:09:40,230 --> 01:09:46,030 So and the feedback and that was in the first year for doing that was tremendous. 604 01:09:46,030 --> 01:09:51,190 They really loved it. So and partly because they'd all had to stay at home. 605 01:09:51,790 --> 01:10:00,189 So but they were still able to engage with with with the course in an exciting for these mostly medical students most 606 01:10:00,190 --> 01:10:06,909 of mine in medical but being the biomedical sciences students also take these options as a smaller number of those. 607 01:10:06,910 --> 01:10:17,050 But yeah, um, so I'm hoping we aren't going to just revert too fast to having to do things in the conventional way because I think there's a lot, 608 01:10:17,950 --> 01:10:21,370 there's a lot to be said for using some of these modern technologies. 609 01:10:21,580 --> 01:10:30,400 Now it sounds as if you were using it in a fairly inventive way. So is there a movement, do you think, in the university to develop that? 610 01:10:30,850 --> 01:10:38,200 I don't know that what I hear most is the urge to return to good old fashioned normal. 611 01:10:38,560 --> 01:10:43,330 And I you know what? You've been exposed to the educational research as much as I have. 612 01:10:43,330 --> 01:10:47,920 There's you know, there's limited educational value to the purely didactic sessions, isn't there. 613 01:10:47,950 --> 01:10:56,080 You know, and um, and the equivalent on examining, um, which is that one bit of the whole thing I don't like at all, 614 01:10:56,620 --> 01:11:05,620 um, that we, the glimmer of good things was we obviously people weren't able to come to exam schools to do the exams. 615 01:11:05,950 --> 01:11:09,760 So we were allowing people to send in TypeScript. 616 01:11:11,070 --> 01:11:17,050 There was a degree of sort of proctoring to make sure they weren't cheating, but that's what happened. 617 01:11:17,590 --> 01:11:23,440 The back end sort of administrate the the technical side of the administration didn't work brilliantly, 618 01:11:23,440 --> 01:11:27,850 but at least we weren't having to decipher people's awful handwriting, which is just grim. 619 01:11:28,930 --> 01:11:32,919 I've never saw handwriting three, as is a life skill anybody needs to acquire anyway. 620 01:11:32,920 --> 01:11:38,050 So why we forced them to do it? I don't know. Certainly reading it is not a skill I need to acquire. 621 01:11:40,120 --> 01:11:47,500 And tragically they're going back to the you know, I kept all of the clunky bits of. 622 01:11:48,590 --> 01:11:55,430 Computer administration of the exam process. The bits that didn't work very well, but made them revert to handwritten scripts. 623 01:11:58,190 --> 01:12:05,870 Anyway. It's all the wrong bits of conservatism, I'm afraid. Um, but we are hanging on too much. 624 01:12:06,210 --> 01:12:08,510 No, I hope not. I do hope not. 625 01:12:08,930 --> 01:12:15,590 There's always some excuse why it's too difficult to prevent cheating or having the right number of keyboards or something. 626 01:12:19,070 --> 01:12:22,910 So I'm just turning to how the whole thing affected you personally. 627 01:12:23,840 --> 01:12:27,260 I mean, obviously, you had the dispensation to come into the lab, if you like. 628 01:12:27,290 --> 01:12:35,180 Yes. Yes. It was slightly odd when everybody else was saying, gosh, isn't it annoying to be at home all the time of all of us? 629 01:12:35,480 --> 01:12:40,520 I was actually going to the lab all the time, uh, you know, really quite long hours. 630 01:12:41,120 --> 01:12:45,770 So that was a bit odd. Hmm. Yeah. So that was my next question. What kind of did it change that? 631 01:12:45,830 --> 01:12:50,000 The obviously I mean, you are obviously somebody who works very hard anyway, but did it change the hours that you worked? 632 01:12:50,450 --> 01:12:56,960 I don't know if I do. I don't see a virtue in working hard, not when most people think that working smart is a good thing. 633 01:12:57,660 --> 01:13:02,140 Um, I was working long, very long hours and did get very tired. 634 01:13:02,150 --> 01:13:11,380 And Becky, for example, as I'm sure you know, yeah, people that had to do that and home school kids had an extra, you know, very, very challenging. 635 01:13:11,390 --> 01:13:21,410 And given my advanced years, it did affect my health quite badly physically for a while, which is now all resolved. 636 01:13:22,310 --> 01:13:33,200 But no, um, yeah. That level of high stress, intense work for long periods is something that's harder to do when you're in the sixties, to be honest. 637 01:13:35,390 --> 01:13:42,860 So I learnt my limits. And did you feel personally threatened by the possibility of infection before the vaccination came along? 638 01:13:43,690 --> 01:13:47,790 Um. Interesting. 639 01:13:47,910 --> 01:13:51,780 I mean, that's. Yeah. Interestingly, in the P three containment lab. 640 01:13:52,320 --> 01:13:55,110 Not at all. Because I know how to handle the things in there. Yeah. 641 01:13:57,240 --> 01:14:07,530 But, yes, outside the lab, I suppose I was more conscious than the average member of the public about the chance of infection. 642 01:14:08,310 --> 01:14:13,650 So when I was insisting on wearing a mask going into a shop, people would look at me like I was mad. 643 01:14:14,640 --> 01:14:22,080 In the early days. Now people aren't. So the best line to do that, that people are now a little bit odd in wanting to cross the street, 644 01:14:22,080 --> 01:14:27,690 even if on a country road they are walking when the chances of catching something terrifically low. 645 01:14:28,350 --> 01:14:33,360 But no, I don't think in my in my day job, I was exposed to any any high, higher risk. 646 01:14:33,690 --> 01:14:39,360 The slight the only frustrating thing was that at one point, we we were in a we were put into an odd position. 647 01:14:40,350 --> 01:14:41,790 I still understand this to this day. 648 01:14:43,380 --> 01:14:53,100 There wasn't draft edict coming around the university saying thou shalt not work on the variants of concern that have emerged. 649 01:14:53,100 --> 01:14:56,250 This is when alpha and beta were just coming along. 650 01:14:56,940 --> 01:15:02,159 Unless thou hast been vaccinated. And I said, Well, 651 01:15:02,160 --> 01:15:07,379 we are working on them and the vaccine is not available to us because scientific 652 01:15:07,380 --> 01:15:11,640 work is did not count as a category of person that got the vaccine properly, 653 01:15:11,640 --> 01:15:16,050 correctly. But, you know, don't do this, please. 654 01:15:16,080 --> 01:15:18,870 This is rather important that we managed to establish. 655 01:15:18,870 --> 01:15:23,910 Whether the current vaccines are giving protection against these new variants is one of the things that we did. 656 01:15:26,730 --> 01:15:33,420 So that went on for a surprisingly long time, the sort of threats to close this down that went away. 657 01:15:33,720 --> 01:15:38,280 I still don't know this day what really motivated all that. There was some being some its bonnet. 658 01:15:39,270 --> 01:15:42,929 Uh, but no, I didn't. And I have. 659 01:15:42,930 --> 01:15:46,740 I haven't caught the virus after after my two doses of vaccine. 660 01:15:47,160 --> 01:15:50,280 I got the the the April wave, like many people did. 661 01:15:50,620 --> 01:15:54,390 Um, April 21. April this year. 662 01:15:54,570 --> 01:15:57,980 Oh, yes, yes, yes. Uh, back to probably. 663 01:15:57,990 --> 01:16:02,160 Yes. Um, uh, and it wasn't very pleasant, actually. 664 01:16:02,170 --> 01:16:09,149 11 days of antigen positivity and, and in bed for a two or three days feeling really quite sorry for myself. 665 01:16:09,150 --> 01:16:18,450 But. But no actual snow, no severe temp, no temperature, and no oxygen depression. 666 01:16:18,450 --> 01:16:26,279 So nothing. Nothing. Nothing to complain about, frankly, uh, this goes to show this thing is quite, quite good. 667 01:16:26,280 --> 01:16:30,210 It'll be infecting you even after you think you've had immunity. 668 01:16:30,430 --> 01:16:38,130 Mm. And were you involved in the COVID safety regime for the department? 669 01:16:38,440 --> 01:16:42,150 We did. We know that they did the university. 670 01:16:42,450 --> 01:16:44,880 Well, there was in the eighties in the university. 671 01:16:45,280 --> 01:16:50,720 No, we had a we had a I think it's a silver group with one of those precious metal groups in the department. 672 01:16:51,330 --> 01:16:57,420 But quite rightly that didn't involve me or anybody that was had a vested interest in it. 673 01:16:57,440 --> 01:17:04,169 Yeah. So that involved senior members administration and and academics not involved in 674 01:17:04,170 --> 01:17:07,860 that and including microbiologist not involved in this House committee stuff. 675 01:17:08,460 --> 01:17:17,190 But then that was, that'll work pretty well. Um, they were possibly more cautious than I would have been about the general return to work thing. 676 01:17:18,000 --> 01:17:20,040 They wanted to be on the safe side, 677 01:17:20,040 --> 01:17:29,759 which I think the downsides of having a scientific environment becomes less vibrant is it was worth weighing or any, 678 01:17:29,760 --> 01:17:34,700 but it did quite a good job and I wouldn't have wanted to be in that. 679 01:17:34,860 --> 01:17:39,860 Yes. And do you think I mean, 680 01:17:39,860 --> 01:17:51,980 a lot of people found the the regulations and the conditions that they had to live under quite hard in various psychological as well as physical ways. 681 01:17:52,490 --> 01:17:55,969 Do you think the fact that you were able to work on something that was going to 682 01:17:55,970 --> 01:18:00,080 contribute to solving the problem might help to support your own work smoothly. 683 01:18:00,290 --> 01:18:05,540 Yeah. I have overworking, I think. Yeah, I think I would find it extremely hard. 684 01:18:07,250 --> 01:18:14,329 Uh, they're extremely hard not to have been able to go to work, because there's only so much I can do. 685 01:18:14,330 --> 01:18:22,580 Theoretically, I'm not a theoretician. Um, so I am very glad that I was able to do something practical. 686 01:18:22,580 --> 01:18:29,600 And I think that might, in the back of my mind, swayed because it was a matter of choices whether I volunteered to do this, this thing or not. 687 01:18:29,600 --> 01:18:33,140 And I think that was probably at the back of my mind. I don't want to be twiddling my thumbs. 688 01:18:34,010 --> 01:18:40,069 I can do this. I should do this. I will do this sort of thing. Um, so, yeah, exactly. 689 01:18:40,070 --> 01:18:43,639 Um, enforced idleness would not have suited me at all. 690 01:18:43,640 --> 01:18:48,020 I don't think voluntary idleness now is looking more and more appealing. 691 01:18:48,060 --> 01:18:51,290 But it isn't, it's not going to come any time soon. 692 01:18:51,680 --> 01:19:00,770 Mhm. And have you been involved in any national bodies that have had to do with policy in any. 693 01:19:01,470 --> 01:19:09,950 I've been involved in some international bodies but long with lots and lots and lots of other people. 694 01:19:10,190 --> 01:19:15,499 But no, not on the not on those ones that you hear about that are advising governments on which vaccines to deploy or. 695 01:19:15,500 --> 01:19:25,190 No, none of those. Uh, I'm not sure that I well, anybody who knows about the viruses could be useful on those things, 696 01:19:25,190 --> 01:19:30,110 but I think the people are more use for the public health physician and so on, frankly. 697 01:19:30,110 --> 01:19:37,040 Um, uh, yes, in advising on public policy in these areas, not something I will have to do. 698 01:19:37,820 --> 01:19:44,790 But pandemic preparedness generally presumably involves making decisions about what kind of research needs supporting. 699 01:19:44,810 --> 01:19:53,629 Yes, yes, absolutely. So I, I don't have any positions of responsibility there, but I do have very close connections with, uh, with the people who do. 700 01:19:53,630 --> 01:19:58,910 And so we discuss these sorts of things like quite happy with that having had six years of this previous done. 701 01:19:58,910 --> 01:20:03,560 So I'm not, not, not looking for extra explicit responsibilities again. 702 01:20:05,270 --> 01:20:08,719 Okay. I think, I think we're pretty much done. Yeah. Um, so my, 703 01:20:08,720 --> 01:20:16,160 my final question is whether the experience of working on these SARS-CoV-2 problems has changed your attitude or your 704 01:20:16,160 --> 01:20:22,240 approach to your work and what it hasn't given you insight into things that you might want to change in the future? 705 01:20:22,250 --> 01:20:25,430 Gosh. Well, I think so. I think we've we touched on a few of these, haven't we? 706 01:20:25,430 --> 01:20:29,120 So I think patterns of work can change a bit. 707 01:20:29,810 --> 01:20:34,160 There are things about the old pattern of work that are worth getting back a little bit. 708 01:20:34,430 --> 01:20:37,729 Patterns of teaching can change and should change. 709 01:20:37,730 --> 01:20:42,270 Patterns of examining should change in much, much more, much, much more. 710 01:20:42,320 --> 01:20:45,320 Right. I'm a bit of a radical about examining. Um. 711 01:20:47,890 --> 01:20:51,040 Yeah. Life generally. Yeah. So. Yeah. 712 01:20:51,040 --> 01:20:54,520 So so wasn't well it. 713 01:20:57,310 --> 01:21:02,920 I don't know if you around Oxford at the time in that first lockdown how quiet the place was to 714 01:21:02,920 --> 01:21:09,440 work at walking direct is when the only person in the middle of a working day in the square. 715 01:21:10,330 --> 01:21:16,510 Absolute silence. And at first I thought, Oh, isn't this charming? 716 01:21:17,830 --> 01:21:24,040 And I thought, No, it's actually a bit post-apocalyptic. And then I sort of have that add. 717 01:21:24,040 --> 01:21:29,139 It had the reverse thing earlier on this year, especially around Easter, 718 01:21:29,140 --> 01:21:34,900 where I was walking Interactive Square and you couldn't get through it because of all the tourists and everything else. 719 01:21:34,900 --> 01:21:42,130 So. Which one? I don't know. It's made me even less inclined to go travelling than I. 720 01:21:42,730 --> 01:21:51,190 Otherwise I'm not a great traveller. I don't. I'm not keen on globetrotting and so on, and I've used as an excuse not to do that. 721 01:21:51,820 --> 01:21:55,270 And plus the environmental excuse not to do that. Um. 722 01:21:58,110 --> 01:22:03,480 But I yes, I think yes, I think that's that's just maybe which is things I probably would have done that way anyway. 723 01:22:06,330 --> 01:22:09,390 This is an awkward thing to tackle in the end, but I forgot to ask it earlier. 724 01:22:11,010 --> 01:22:14,100 But was it easy to get funding for the work that you've done? 725 01:22:15,690 --> 01:22:21,120 There was. Well, we should give a plug. I don't know if you use your tokens them elsewhere, 726 01:22:21,120 --> 01:22:34,080 but the Development Office and the Medical Sciences Development Team did an excellent job of rattling the cans and got a strategic fund together. 727 01:22:34,450 --> 01:22:42,450 Attitude. Patrick Grant It's about that whole area and that was administered in a, in a, in a very imaginative way. 728 01:22:42,480 --> 01:22:49,560 Um, um, difficult job to administer that, but they did well, so, so for setting up the, 729 01:22:50,060 --> 01:22:54,360 the service sort of function that we did and for doing one particular piece of 730 01:22:54,360 --> 01:22:59,280 work where applying through the conventional routes would have been far too slow. 731 01:23:00,150 --> 01:23:07,860 Um, that's enabled us to do what we needed to do. Um, um, and I think quite a lot of groups around Oxford found that as well. 732 01:23:07,860 --> 01:23:21,659 So that's been brilliant. Um, we've continued in, uh, in a certain respect to use, to use, to work with philanthropists, 733 01:23:21,660 --> 01:23:28,110 donors to fund research since, um, in a way that's wasn't normal before, actually. 734 01:23:28,710 --> 01:23:32,730 Um, and I think maybe that sort of culture has changed a little bit. 735 01:23:33,720 --> 01:23:39,850 Um, it's different, but, um, yeah, so it's, it's another way of getting, uh, 736 01:23:40,110 --> 01:23:45,719 the science that needs to be done, supported and engaging a wider range of people in science. 737 01:23:45,720 --> 01:23:49,800 So that's been good as well. Good. 738 01:23:52,310 --> 01:23:52,610 Good.